Extralysosomal protein degradation in myofibrillar myopathies: Mini-symposium: Protein aggregate myopathies

Brain Pathology

Volumn 19, Issue 3, 2009, Pages 507-515

  Olivé, Montse ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Myofibrillar myopathies; Neuron restrictive silencer factors; Proteasome system; Protein aggregates; Ubiquitin

Indexed keywords

MUSCLE PROTEIN; MUTANT PROTEIN; PROTEASOME; UBIQUITIN; UBIQUITIN THIOLESTERASE;

AGGRESOME; CONFERENCE PAPER; HEART MUSCLE; HISTOPATHOLOGY; HUMAN; MORPHOLOGY; MUSCLE CELL; MYOPATHY; OXIDATIVE STRESS; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SKELETAL MUSCLE;

ANIMALS; HUMANS; LYSOSOMES; MUSCULAR DISEASES; MYOFIBRILS; PROTEINS;

EID: 66949120632     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2009.00288.x     Document Type: Conference Paper

References (78)

1. Ardley HC, Scott GB, Rose SA, Tan NG, Robinson PA (2004) UCH-l1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease. J Neurochem 90 : 379 391. (Pubitemid 38938224)
2. Arthur PG, Grounds MD, Shavlakadze T (2008) Oxidative stress as a therapeutic target during muscle wasting: considering the complex interactions. Curr Opin Clin Nutr Metab Care 11 : 408 416.
3. Bär H, Strelkov SV, Sjöberg G, Aebi U, Herrmann H (2004) The biology of desmin filaments: how do mutations affect their structure, assembly and organisation. J Struct Biol 148 : 137 152. (Pubitemid 39346004)
4. Bär H, Fischer D, Goudeau B, Kley RA, Clemen CS, Vicart P et al (2005) Pathogenic effects of a novel heterozygous R350P desmin mutation on the assembly of desmin intermediate filaments in vivo and in vitro. Hum Mol Genet 14 : 1251 1260. (Pubitemid 40744485)
5. Bär H, Mücke N, Ringler P, Müller SA, Kreplak L, Katus HA et al (2006) Impact of disease mutations on the desmin filament assembly process. J Mol Biol 360 : 1031 1042. (Pubitemid 44062518)
6. Barrachina M, Moreno J, Juvés S, Moreno D, Olivé M, Ferrer I (2007) Target genes of neuron-restrictive silencer factor are abnormally up-regulated in human myotilinopathy. Am J Pathol 171 : 1312 1323. (Pubitemid 47582904)
7. Bruce AW, Donaldson IJ, Wood IC, Yerbury SA, Sadowski MI, Chapman M et al (2004) Genome-wide analysis of repressor element 1 silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) target genes. Proc Natl Acad Sci U S A 101 : 10458 10463. (Pubitemid 38924947)
8. Carrell RW, Lomas DA (1997) Conformational disease. Lancet 350 : 134 138. (Pubitemid 27313650)
9. Chávez Zobel AT, Loranger A, Marceau N, Thériault JR, Lambert H, Landry J (2003) Distinct chaperone mechanisms can delay the formation of aggresomes by the myopathy-causing R120G alpha-B-crystallin mutant. Hum Mol Genet 12 : 1609 1620. (Pubitemid 36857307)
10. Choi-Miura NH, Oda T (1996) Relationship between multifunctional protein "clusterin" and Alzheimer disease. Neurobiol Aging 17 : 717 722. (Pubitemid 26348872)
11. Chong JA, Tapia-Ramírez J, Kim S, Toledo-Aral JJ, Zheng Y, Boutros MC et al (1995) REST: a mammalian silencer protein that restricts sodium channel gene expression to neurons. Cell 80 : 949 957.
12. Davies KJA (2001) Degradation of oxidized proteins by the 20S proteasome. Biochimie 83 : 301 310. (Pubitemid 32293650)
13. Davies KJA, Shringarepure R (2006) Preferential degradation of oxidized proteins by the 20S proteasome may be inhibited in aging and inflammatory neuromuscular diseases. Neurology 66 (Suppl. 1 s93 s96.
14. De Bleecker JL, Engel AG, Ertl B (1996) Myofibrillar myopathy with foci of desmin positivity. II. Immunocytochemical analysis reveals accumulation of multiple other proteins. J Neuropathol Exp Neurol 55 : 563 577. (Pubitemid 26140839)
15. de Pril R, Fischer DF, van Leeuwen FW (2006) Conformational diseases: an umbrella for various neurological disorders with an impaired ubiquitin-proteasome system. Neurobiol Aging 27 : 515 523. (Pubitemid 43290520)
16. Ellis RJ, Pinheiro TJT (2002) Danger-misfolded proteins. Nature 416 : 483 484.
17. Ferrer I, Olivé M (2008) Molecular pathology of myofibrillar myopathies. Expert Rev Mol Med 10 : e25. doi:10.1017/S1462399408000793
18. Ferrer I, Matín B, Castaño JG, Lucas JJ, Moreno D, Olivé M (2004) Proteasomal expression, induction of immunoproteasome subunits, and local MHC class I presentation in myofibrillar myopathy and inclusion body myositis. J Neuropathol Exp Neurol 63 : 484 498. (Pubitemid 38669669)
19. Ferrer I, Carmona M, Blanco R, Moreno D, Torrejón-Escribano B, Olivé M (2005) Involvement of clusterin and the aggresome in abnormal protein deposits in myofibrillar myopathies and inclusion body myositis. Brain Pathol 15 : 101 108. (Pubitemid 40546164)
20. Fischer DF, De Vos RA, Van Dijk R, De Vrij FM, Proper EA, Sonnemans MA et al (2003) Disease-specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain. FASEB J 17 : 2014 2024. (Pubitemid 37392446)
21. +1 is accumulated in sporadic inclusion-body myositis muscle fibers. Neurology 63 : 1114 1117. (Pubitemid 39287931)
22. Freixes M, Puig B, Rodríguez A, Torrejón-Escribano B, Blanco R, Ferrer I (2004) Clusterin solubility and aggregation in Creutzfeldt-Jakob disease. Acta Neuropathol 108 : 295 301. (Pubitemid 39328047)
23. Gao X, Hu H (2008) Quality control of the proteins associated with neurodegenerative diseases. Acta Biochim Biophys Sin 40 : 612 618. (Pubitemid 352009083)
24. Garvey SM, Miller SE, Claflin DR, Faulkner JA, Hauser MA (2006) Transgenic mice expressing the myotilin T57I mutation unite the pathology associated with LGMD1A and MFM. Hum Mol Genet 15 : 2348 2362. (Pubitemid 44288680)
25. Garvey SM, Liu Y, Miller SE, Hauser MA (2008) Myotilin overexpression enhances myopathology in the LGMD1A mouse model. Muscle Nerve 37 : 663 667. (Pubitemid 351590559)
26. Geetha T, Wooten MW (2005) Structure and functional properties of the ubiquitin binding protein p62. FEBS Lett 512 : 19 24.
27. Glickman MH, Ciechanover A (2002) The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82 : 373 428. (Pubitemid 34654457)
28. Goebel HH, Muller HD (2006) Protein aggregate myopathies. Semin Pediatr Neurol 13 : 96 103. (Pubitemid 44486824)
29. Goebel HH, Fardeau M, Olivé M, Schröder R (2008) 156th ENMC International Workshop: desmin and protein aggregate myopathies, 9-11 November 2007, Naarden, The Netherlands. Neuromuscul Disord 18 : 583 592.
30. Goldfarb LG, Park KY, Cervenáková L, Gorokhova S, Lee HS, Vasconcelos O et al (1998) Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat Genet 19 : 402 403. (Pubitemid 28357917)
31. Goldfarb LG, Vicart P, Goebel HH, Dalakas MC (2004) Desmin myopathy. Brain 127 : 723 734. (Pubitemid 38478517)
32. Grune T, Jung T, Merker K, Davies KJ (2004) Decreased proteolysis caused by protein aggregates, inclusion body, plaques, lipofuscin, ceroid, and aggresomes during oxidative stress, aging, and disease. J Biol Chem 36 : 2519 2530. (Pubitemid 39119763)
33. Janué A, Odena MA, Oliveira E, Olivé M, Ferrer I (2007) Desmin is oxidized and nitrated in affected muscles in myotilinopathies and desminopathies. J Neuropathol Exp Neurol 66 : 711 723. (Pubitemid 47344250)
34. Janué A, Olive M, Ferrer I (2007) Oxidative stress in desminopathies and myotilinopathies: a link between oxidative damage and abnormal protein aggregation. Brain Pathol 17 : 377 388. (Pubitemid 47537595)
35. Jones SE, Jomary C (2002) Clusterin. Int J Biochem Cell Biol 34 : 427 431. (Pubitemid 34242756)
36. Kopito RR (2000) Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 10 : 524 530.
37. Kostova Z, Wolf DH (2003) For whom the bell tolls: protein quality control of the endoplasmic reticulum and the ubiquitin-proteasome connection. EMBO J 22 : 2309 2317. (Pubitemid 36604970)
38. Lindsten K, de Vrij FM, Verhoef LG, Fischer DF, van Leeuwen FW, Hol EM et al (2002) Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation. J Cell Biol 157 : 417 427. (Pubitemid 34839806)
39. Liu J, Chen Q, Huang W, Horak KM, Zheng H, Mestril R, Wang X (2006) Impairment of the ubiquitin-proteasome system in desminopathy mouse hearts. FASEB J 20 : 362 364. (Pubitemid 46671172)
40. Liu J, Tang M, Mestril R, Wang X (2006) Aberrant protein aggregation is essential for a mutant desmin to impair the proteolytic function of the ubiquitin-proteasome system in cardiomyocytes. J Mol Cell Cardiol 40 : 451 454.
41. Liu Y, Fallon L, Lashuel HA, Liu Z, Lansbury PT Jr. (2002) The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell 111 : 209 218. (Pubitemid 35292441)
42. Löwe T, Kley RA, van der Ven PF, Himmel M, Huebner A, Vorgerd M, Fürst DO (2007) The pathomechanism of filaminopathy: altered biochemical properties explain the cellular phenotype of a protein aggregation myopathy. Hum Mol Genet 16 : 1351 1358. (Pubitemid 47055131)
43. Muñoz-Mármol AM, Strasser G, Isamat M, Coulombe PA, Yang Y, Roca X et al (1998) A dysfunctional desmin mutation in a patient with severe generalised myopathy. Proc Natl Acad Sci U S A 95 : 11312 11317. (Pubitemid 28450125)
44. Nakano S, Engel AG, Waclawik AJ, Emslie-Smith AM, Busis NA (1996) Myofibrillar myopathy with abnormal foci of desmin positivity. I. Light and electron miscroscopy analysis of 10 cases. J Neuropathol Exp Neurol 55 : 549 562. (Pubitemid 26140838)
45. Olivé M, Goldfarb LG, Shatunov A, Fischer D, Ferrer I (2005) Myotilinopathy: refining the clinical and myopathological phenotype. Brain 128 : 2315 2326. (Pubitemid 41407972)
46. Olivé M, van Leeuwen FW, Janué A, Moreno D, Torrejón-Escribano B, Ferrer I (2008) Expression of mutant ubiquitin (UBB+1) and p62 in myotilinopathies and desminopathies. Neuropathol Appl Neurobiol 34 : 76 87.
47. Olivé M, Janué A, Moreno D, Gámez J, Torrejón-Escribano B, Ferrer I (2009) TAR DNA-binding protein 43 accumulation in protein aggregate myopathies. J Neuropathol Exp Neurol 68 : 262 273.
48. Paine MG, Babu JR, Seibenhener ML, Wooten MW (2005) Evidence for p62 aggregate formation: role in cell survival. FEBS Lett 579 : 5029 5034. (Pubitemid 41242848)
49. Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H et al (2007) p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 282 : 24131 24145. (Pubitemid 47328003)
50. Piec I, Listrat A, Alliot J, Chambon C, Taylor RG, Bechet D (2005) Differential proteome analysis of aging in rat skeletal muscle. FASEB J 19 : 1143 1145. (Pubitemid 40946445)
51. Poppek D, Grune T (2006) Proteasomal defense of oxidative protein modifications. Antioxid Redox Signal 8 : 173 184. (Pubitemid 43324544)
52. Raju R, Dalakas MC (2007) Absence of upregulated genes associated with protein accumulations in desmin myopathy. Muscle Nerve 35 : 386 388. (Pubitemid 46364096)
53. Reimann J, Kunz WS, Vielhaber S, Kappes-Horn K, Schröder R (2003) Mitochondrial dysfunction in myofibrillar myopathy. Neuropathol Appl Neurobiol 29 : 45 51. (Pubitemid 36238116)
54. Rosenberg ME, Silkensen J (1995) Clusterin: physiological and pathological considerations. Int Biochem Cell Biol 27 : 633 645.
55. Rubinsztein DC (2006) The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443 : 780 786. (Pubitemid 44622682)
56. Sanbe A, Osinska H, Saffitz JE, Glabe CG, Kayed R, Maloyan A, Robbins J (2004) Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis. Proc Natl Acad Sci U S A 101 : 10132 10136. (Pubitemid 38891207)
57. Sasaki K, Doh-ura K, Wakisaka Y, Iwaki T (2002) Clusterin/Apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies. Acta Neuropathol 104 : 225 230. (Pubitemid 36075383)
58. Schoenherr CJ, Anderson DJ (1995) The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes. Science 267 : 1360 1363.
59. Schröder R, Goudeau B, Simon MC, Fischer D, Eggermann T, Clemen CS et al (2003) On noxious desmin: functional effects of a novel heterozygous desmin insertion mutation on the extrasarcomeric desmin cytoskeleton and mitochondria. Hum Mol Genet 12 : 657 669. Erratum in: Hum Mol Genet (2007) 16:2989-2990. (Pubitemid 36372492)
60. Seibenhener ML, Babu JR, Geetha T, Wong HC, Krishna NR, Wooten MW (2004) Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol Cell Biol 24 : 8055 8068. (Pubitemid 39167456)
61. Seibenhener ML, Geetha T, Wooten MW (2007) Sequestrosome 1/p62 - more than just a scaffold. FEBS Lett 581 : 175 179. (Pubitemid 46096472)
62. Selcen D, Engel AG (2004) Mutations in myotilin cause myofibrillar myopathy. Neurology 62 : 1363 1371. (Pubitemid 38526050)
63. Selcen D, Engel AG (2005) Mutations in ZASP define a novel form of muscular dystrophy in humans. Ann Neurol 57 : 269 276. (Pubitemid 40179865)
64. Selcen D, Ohno K, Engel AG (2004) Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients. Brain 127 : 439 451. (Pubitemid 38160328)
65. Selcen D, Muntoni F, Burton BK, Pegoraro E, Sewry C, Bite AV, Engel AG (2008) Mutation in BAG3 causes severe dominant childhood muscular dystrophy. Ann Neurol 65 : 83 89.
66. Setsuie R, Wada K (2007) The functions of UCH-L1 and its relation to neurodegenerative diseases. Neurochem Int 5 : 105 111. (Pubitemid 47179898)
67. Sherman MY, Al G (2001) Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative disease. Neuron 29 : 15 32. (Pubitemid 32108719)
68. Sjöberg G, Saavedra-Matiz CA, Rosen DR, Wijsman EM, Borg K, Horowitz SH, Sejersen T (1999) Missense mutation in the desmin rod domain is associated with autosomal dominant distal myopathy and exerts a dominant negative effect on filament formation. Hum Mol Genet 8 : 2191 2198. (Pubitemid 29525333)
69. Stagsted J, Bendixen E, Andersen HJ (2004) Identification of specific oxidatively modified proteins in chicken muscles using a combined immunologic and proteomic approach. J Agric Food Chem 52 : 3967 3974.
70. Tai HC, Schuman EM (2008) Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction. Nat Rev Neurosci 9 : 826 838.
71. Trougakos IP, Gonos ES (2006) Regulation of clusterin/ apolipoprotein J, a functional homologue to the small heat shock proteins, by oxidative stress in ageing and age-related diseases. Free Radic Res 40 : 1324 1334. (Pubitemid 44698281)
72. van Leeuwen FW, de Kleijn DP, van den Hurk HH, Neubauer A, Sonnemans MA, Sluijs JA et al (1998) Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science 279 : 242 247. (Pubitemid 28103884)
73. Vicart P, Caron A, Guicheney P, Li Z, Prévost MC, Faure A et al (1998) A missense mutation in the αB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet 20 : 92 95. (Pubitemid 28410353)
74. Vorgerd M, van der Ven PF, Bruchertseifer V, Löwe T, Kley RA, Schröder R et al (2005) A mutation in the dimerization domain of filamin causes a novel type of autosomal dominant myofibrillar myopathy. Am J Hum Genet 77 : 297 304. (Pubitemid 41022711)
75. Wang X, Osinska H, Dorn GW, Nieman M, Lorenz JN, Gerdes AM et al (2001) Mouse model of desmin-related cardiomyopathy. Circulation 103 : 2402 2407. (Pubitemid 32448807)
76. Wang X, Osinska H, Klevitsky R, Gerdes AM, Nieman M, Lorenz J et al (2001) Expression of R120G-αB-crystallin causes aberrant desmin and αB-crystallin aggregation and cardiomyopathy in mice. Circ Res 89 : 84 91. (Pubitemid 34135496)
77. Winslow AR, Rubinsztein DC (2008) Autophagy in neurodegeneration and development. Biochim Biophys Acta 1782 : 723 729.
78. Zatloukal K, Stumptner C, Fuchsbichler A, Heid H, Schnoelzer M, Kenner L et al (2002) p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol 160 : 255 263. (Pubitemid 34052286)